MOGAD optic neuritis post enterovirus meningitis: a new association Authors: Salman Aljarallah, Othman O Aldraihem, Khalid Alqarni Published: 2026 ABSTRACT AbstractIntroductionMyelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune demyelinating disorder of the central nervous system, typically presenting with optic neuritis, transverse myelitis or acute disseminated encephalomyelitis. While viral triggers such as Epstein-Barr virus and adenovirus have been reported, an association with enterovirus meningitis is not well documented.Case presentationWe report a 17-year-old female who presented with enterovirus meningitis confirmed by cerebrospinal fluid PCR and leptomeningeal enhancement on MRI. One week later, she developed right optic neuritis with MRI-confirmed optic nerve enhancement. Serum myelin oligodendrocyte glycoprotein-IgG was positive (1:160), confirming MOGAD. She fully recovered after intravenous steroids and oral taper.ConclusionThis case suggests enterovirus meningitis may trigger MOGAD and highlights the need to consider post-infectious demyelination in patients with new neurological symptoms following viral meningitis.Keywords: NEUROIMMUNOLOGY Introduction Myelin oligodendrocyte glycoprotein (MOG) is a protein found only in the outer layers of myelin and oligodendrocyte membranes in the central nervous system (CNS). MOG antibody-associated disease (MOGAD) is a rare autoimmune condition in which antibodies trigger an inflammatory demyelinating disorder of the CNS. The exact mechanism of MOG antibody production, as well as the cause of blood–brain barrier (BBB) disruption, remains unknown.1 A prior infection with Epstein-Barr virus (EBV), which predominantly affects B cells, has been suggested as a potential trigger for MOGAD.2 It can present in several different ways, ranging from optic neuritis to transverse myelitis and in some cases, acute disseminated encephalomyelitis or cortical encephalitis.3 Furthermore, it can be preceded by viral prodromal-like symptoms including dizziness, headache, worsening nausea and vomiting.4 Aseptic meningitis can be caused by various autoimmune diseases, such as lupus, rheumatoid arthritis and sarcoidosis. Aseptic meningitis has also been seen in conditions such as Vogt-Koyanagi-Harada syndrome, granulomatosis with polyangiitis and Behçet’s disease. Furthermore, aseptic meningitis, with or without leptomeningeal enhancement can be the initial manifestation of MOGAD. Moreover, adenovirus meningitis has also been reported prior to the development of MOGAD.5 6 To date, the occurrence of enterovirus meningitis followed by postinfectious MOGAD has not been reported in the literature. This possible link represents a novel observation and may suggest a broader role for viral infections in triggering MOGAD, highlighting the need for further investigation into postviral immune responses within the CNS. Case presentation We present a case of a 17-year-old previously healthy Middle Eastern female presented to a peripheral hospital with a 3-day history of headache, subjective fever and neck stiffness. She had no prior neurological or autoimmune conditions. Family history was notable for vitiligo and hypothyroidism in a maternal aunt. On admission, empiric intravenous ceftriaxone, vancomycin and acyclovir were initiated for suspected meningitis. Initial blood work including complete blood count and inflammatory markers were unremarkable except for low haemoglobin, haematocrit (HCT) and mean corpuscular haemoglobin (MCH). Cerebrospinal fluid (CSF) analysis revealed elevated white blood cells (WBCs) at 78 cells/mm³, with a lymphocytic predominance (98%), mild red blood cell presence (2 /mm³), normal glucose of 2 mmol/L and no organisms on Gram stain. Bacterial cultures, tuberculosis PCR and yeast PCR from CSF were all negative. However, a viral meningitis PCR panel returned positive for enterovirus. Brain MRI with contrast showed bilateral smooth linear leptomeningeal enhancement, particularly in the parieto-occipital region, concerning for infectious or inflammatory processes (figure 1). The patient showed clinical improvement with supportive care and was discharged after 5 days. MRI brain postcontrast showing bilateral minor smooth linear leptomeningeal enhancement of the cerebral hemispheres, most notably in the parietooccipital regions. 1 week later, she presented again with acute-onset blurry vision in her right eye, which progressed over 3 days to complete visual loss. There was no eye pain or systemic symptoms. Neurological and fundoscopic examinations were not available, and documentation of these assessments could not be obtained. Humphrey visual field test reported dense visual field defect in inferior quadrants and superonasal quadrant of the right eye. A repeat MRI of the brain, orbits and cervical spine with contrast showed interval resolution of leptomeningeal enhancement. However, the intraorbital segment of the right optic nerve was swollen, with abnormal T2 hyperintensity extending into the optic canal and contrast enhancement findings consistent with optic neuritis (online supplemental figure 1). The optic chiasm and left optic nerve were normal. The patient was treated with intravenous methylprednisolone (1 g daily for 5 days), with partial visual improvement by day 3 and full recovery by day 5. She was transferred to our tertiary hospital for further evaluation. Day 2 after 5 doses of daily intravenous methylprednisolone, the visual acuity recovered to 20/20. Repeated Humphrey visual field test, performed 7 days after the initial one, reported visual field defect in inferior quadrants and superonasal quadrant of the right eye, but better than before. Serum testing was positive for elevated MOG-IgG antibodies, with a titre of 1:160. The assay was performed at Quest Diagnostics using a cell-based immunofluorescence assay. Testing for aquaporin-4 (AQP4) antibodies was negative. A follow-up CBC demonstrated neutrophilia (8.0×10⁹/L), lymphopenia (0.98×10⁹/L) and monocytopenia (0.09×10⁹/L), with an ESR of 6 mm/hour. Repeat CSF testing revealed lymphocytic WBCs of 7 cells/mm³, normal protein of 0.25 g/L, normal glucose of 3 mmol/L, negative for MOG-IgG, AQP4 antibodies and oligoclonal bands. After completing intravenous steroids, the patient was started on oral steroids taper over 6 months in total, initiated with 60 mg oral prednisone daily for 1 week, reduced by 5 mg weekly for 8 weeks to 15 mg/day, then followed by a slower reduction of 2.5 mg every 2 weeks for 12 weeks until fully stopped. This is in accordance with a recent study that suggests the steroids dose to be maintained at >12.5 mg/day for at least 3 months for better relapse control.7 8 The diagnosis of MOGAD was made based on the presence of a core clinical feature (optic neuritis) with a clear positive (1:>160) serum MOG antibody titre using cell-based immunofluorescence assay. The patient fulfilled the International MOGAD Panel proposed criteria.9 In her most recent follow-up, 7 months after the initial optic neuritis, the patient reports no neurological symptoms except persistent weekly headaches. She finished her steroid tapering course 2 weeks prior to this assessment. Discussion Enteroviruses are one of the most common viral pathogens affecting humans. They can lead to many neurological, pulmonary, gastrointestinal and dermatological manifestations. The virus has many serotypes with a variety of pathological features. Neurological manifestations include aseptic meningitis, encephalitis, myelitis and acute flaccid paralysis, among others.10 They are known as the most common cause of aseptic meningitis, which is a term used to describe inflammation of the meninges, the membranes covering the brain and spinal cord, caused by various factors and characterised by negative CSF bacterial cultures. This condition is typically diagnosed based on CSF pleocytosis, indicated by an elevated WBC count.11 In this case, we describe a unique presentation of MOGAD that developed shortly after a confirmed diagnosis of enterovirus meningitis in a previously healthy adolescent. To our knowledge, this is the first report suggesting a temporal association between enterovirus meningitis and subsequent MOGAD. While postinfectious MOGAD has been linked to viral triggers such as EBV and adenovirus,2 6 the role of enterovirus has not been documented. The virus can cross the BBB by several proposed mechanisms, such as infecting cerebral microvascular endothelial cells, travelling retrograde along peripheral motor nerves or trojan horse inside infected immune cells. Both of enteroviruses and MOGAD can cause CNS inflammation and neurological deficits, but enterovirus is driven by direct viral invasion/replication while MOGAD is an antibody-mediated autoimmune demyelinating disorder. Enteroviral injury combines cytopathic effects and immune-mediated damage; MOGAD causes complement-rich, perivenous demyelination with secondary inflammation. BBB disruption occurs in both—via viremia/neural spread in enterovirus and cytokine-driven immune trafficking in MOGAD. Although perivascular cuffing occurs in enterovirus CNS infections, it is dominated by CD68+ macrophage/microglial cells with sparse CD8+ T cells, while CD4+ T cells are the dominating immune cells in MOGAD with predilection to perivenules.12,14 This difference in immune cells distribution could be because of the acute nature of enterovirus CNS infections with innate immune responses as opposed to MOGAD with adaptive immunity. In this patient, the brief latency period between the viral meningitis and the onset of optic neuritis—along with positive serum MOG-IgG antibodies—supports a postinfectious autoimmune mechanism that could be triggered by molecular mimicry.15 Interestingly, the initial MRI findings of leptomeningeal enhancement are not typically described in classic MOGAD but have been reported in recent literature in cases with aseptic meningitis-like presentations.5 The transient enhancement seen here likely reflects inflammatory changes due to viral meningitis, later followed by demyelinating involvement of the optic nerve—a pattern aligning with a biphasic illness triggered by CNS infection. The patient’s rapid and complete response to intravenous steroids highlights the favourable prognosis often associated with MOGAD, especially when promptly recognised and treated.16 This case, along with a reported case of MOGAD following adenovirus meningitis suggests that viral meningitis may act as a trigger for autoimmune demyelination.6 It also emphasises the importance of considering MOGAD in patients presenting with optic neuritis following CNS infections, particularly when initial CSF and MRI findings point to non-bacterial meningeal inflammation. However, these are isolated cases, and a definitive causal link between viral meningitis and the development of MOGAD has not been established. Conclusion This case highlights a potential novel association between enterovirus meningitis and the subsequent development of MOG antibody-associated optic neuritis. It expands the spectrum of infections that may precede MOGAD and suggests a need for heightened clinical vigilance for demyelinating complications in patients recovering from viral meningitis. Supplementary material Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Consent obtained directly from patient(s). Ethics approval: Written informed consent for publication of the clinical details and accompanying images was obtained from the patient. As this report involves no research procedures beyond standard clinical care, formal institutional ethics committee approval was not applicable, and no additional human participants were included. Data availability statement Data sharing not applicable as no datasets generated and/or analysed for this study. References Associated Data Supplementary Materials Data Availability Statement Data sharing not applicable as no datasets generated and/or analysed for this study.